|
Volumn 1, Issue 5, 2006, Pages 1090-1099
|
Management of dyslipidemias in patients with diabetes and chronic kidney disease.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HDL TRIGLYCERIDE;
HDL-TRIGLYCERIDE;
HIGH DENSITY LIPOPROTEIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
TRIACYLGLYCEROL;
UNCLASSIFIED DRUG;
BLOOD;
CARDIOVASCULAR DISEASE;
CHRONIC KIDNEY FAILURE;
DIABETIC NEPHROPATHY;
DISEASE COURSE;
DYSLIPIDEMIA;
GLOMERULUS FILTRATION RATE;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
KIDNEY TRANSPLANTATION;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATHOPHYSIOLOGY;
REVIEW;
TREATMENT OUTCOME;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 1;
DIABETES MELLITUS, TYPE 2;
DIABETIC NEPHROPATHIES;
DISEASE PROGRESSION;
DYSLIPIDEMIAS;
GLOMERULAR FILTRATION RATE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
LIPOPROTEINS, HDL;
TREATMENT OUTCOME;
TRIGLYCERIDES;
|
EID: 34548379454
PISSN: None
EISSN: 1555905X
Source Type: Journal
DOI: 10.2215/CJN.00780306 Document Type: Review |
Times cited : (64)
|
References (75)
|